REMUS PHARMACEUTICALS L Share Price

Remus Pharmaceuticals Limited is an India-based company, which is engaged in marketing and distribution of finished formulations of pharmaceutical drugs. The Company also deals in active pharmaceutical ingredients (APIs). It also provides technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. It offers a range of pharmaceutical formulations and products manufactured on contract manufacturing and on a loan license basis. It deals in drug forms like capsules, cream, eye drops, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension and tablet. The Company offers its products in various therapeutic categories, such as oncology, cardiovascular, anti-diabetic, central nervous system (CNS), immunosuppressants, anti-biotic - antibacterial and dermatology.As of 26 May 2026, REMUS PHARMACEUTICALS L share price is ₹756.00. The stock opened at ₹755.00, compared to its previous close of ₹760.85. During today's trading session, REMUS PHARMACEUTICALS L share price moved in the range of ₹748.10 to ₹783.00, with an average price of ₹765.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹748.10 and a high of ₹783.00. On the performance front, REMUS PHARMACEUTICALS L share price has increased by 15.25% over the last six months and is down 62.39% on a year-on-year basis.

The market capitalization of REMUS PHARMACEUTICALS L is ₹1,319 Crs, with a P/E ratio of 36.3 and a dividend yield of 0.20%.